| INTRODUC TI ON
.
Resistance against the antiviral drugs occurs through mutations in the viral genome. Resistance to NI is caused by single point mutations in the neuraminidase (NA) gene. Substitutions in several codons have been identified, in vitro, to cause different levels of resistance against the different drugs. 2 The H275Y mutation (N1 numbering) reduces susceptibility of H1N1 influenza virus to oseltamivir by more than 400-fold and also reduces susceptibility to peramivir, but does not cause resistance to zanamivir in vitro. that mutations are present in other positions that make up for the prior disadvantage of the H275Y substitution. 13, 14 Here, we report increased incidences of H1N1 viruses with highly reduced inhibition (HRI) by oseltamivir, possessing the H275Y NA substitution, during the 2015/16 influenza season in Norway. 100-fold increase in IC50 was classified as having "reduced inhibition" (RI) and with more than 100-fold increase in IC50 as "highly reduced inhibition" (HRI). Viruses that could not be propagated for NA susceptibility studies were characterised as "amino acid substitution previously associated with highly reduced inhibition" (AAHRI) by the presence of the H275Y substitution. Nucleotide sequences were further analysed by BioNumerics (Applied Maths, Sint-Martens-Latem, Belgium), BioEdit 20 and MEGA 6 software. 21 Phylogenetic trees were constructed with the neighbor-joining method, using Kimura The outpatient was sampled 3 days before the hospitalised patient (Table 1) .
| ME THODS

| RE SULTS
The phenotypic resistance analysis of viruses that we were able to propagate supported the genetic analysis of oseltamivirresistant viruses, with a 1000-fold increase in IC50 confirming highly reduced inhibition by oseltamivir and normal inhibition by zanamivir (Table 1) . 
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